Early Stage Breast Cancer
Showing 1 - 25 of >10,000
Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2
Recruiting
- HER2-positive Breast Cancer
- Early-stage Breast Cancer
- pyrotinib combined with Capecitabine
- treatment of physician's choice
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Sep 6, 2023
Early-stage Breast Cancer Trial (Huaier granule)
Not yet recruiting
- Early-stage Breast Cancer
- Huaier granule
- (no location specified)
May 12, 2023
Dietary Habits, Nutritional Knowledge and Physical Activity
Recruiting
- Breast Cancer
-
Aviano, Pordonone, ItalyIRCCS, Centro di Riferimento Oncologico (CRO) di Aviano
Oct 5, 2023
Early-stage Breast Cancer Trial in Brno (APBI, WBI)
Completed
- Early-stage Breast Cancer
- APBI
- WBI
-
Brno, Czech Republic, CzechiaMasaryk Memorial Cancer Institute
Aug 17, 2023
Breast Cancer, Early-stage Breast Cancer Trial in Miami (Stereotactic Ablative Breast Radiotherapy)
Recruiting
- Breast Cancer
- Early-stage Breast Cancer
- Stereotactic Ablative Breast Radiotherapy
-
Miami, FloridaUniversity of Miami
Jan 18, 2023
Breast Cancer Trial in Chicago (Cyclophosphamide, Methotrexate, Capecitabine)
Recruiting
- Breast Cancer
- Cyclophosphamide
- +2 more
-
Chicago, IllinoisUniversity of Illinois
Oct 18, 2023
Breast Cancer Stage I Trial (Microwave ablation)
Not yet recruiting
- Breast Cancer Stage I
- Microwave ablation
- (no location specified)
May 23, 2023
Patient Decision Making in Early Stage Breast Cancer:Conjoint
Recruiting
- Triple Negative Breast Cancer
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
Feb 14, 2023
Early-stage Breast Cancer Trial in Ottawa (Endocrine Therapy and Radiotherapy)
Completed
- Early-stage Breast Cancer
- Endocrine Therapy and Radiotherapy
-
Ottawa, Ontario, CanadaOttawa Hospital Research Institute
Sep 28, 2022
Breast Cancer Trial in Birmingham (Single Fraction Stereotactic Body Radiation Therapy)
Recruiting
- Breast Cancer
- 1-3 Fraction Stereotactic Body Radiation Therapy
-
Birmingham, AlabamaUniversity of Alabama at Birmingham (UAB) Hazelrig-Salter Radiat
Jan 23, 2023
Early-stage Breast Cancer, Obesity Trial (Bariatric Surgery with Sleeve Gastrectomy, Lifestyle Intervention)
Not yet recruiting
- Early-stage Breast Cancer
- Obesity
- Bariatric Surgery with Sleeve Gastrectomy
- Lifestyle Intervention
- (no location specified)
Jan 31, 2023
Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,
Not yet recruiting
- Breast Cancer
- +2 more
- Abemaciclib
- +5 more
-
Boston, Massachusetts
- +7 more
Aug 14, 2023
Breast Cancer Trial in Dallas (Radiomics on MRI)
Recruiting
- Breast Cancer
- Radiomics on MRI
-
Dallas, TexasUniversity of Texas Southwestern Medical Center - Dallas
Nov 28, 2022
HER2-positive Breast Cancer Trial in Nanjing (Pyrotinib)
Recruiting
- HER2-positive Breast Cancer
-
Nanjing, Jiangsu, ChinaJiangSu Province Hospital/ The First Affiliated Hospital of Nanj
Apr 26, 2023
Breast Tumor Female, Quality of Life, Psychological Distress Trial in Rome (Patient Reported Outcome (PRO))
Recruiting
- Breast Neoplasm Female
- +2 more
- Patient Reported Outcome (PRO)
-
Rome, Roma, Italy
- +1 more
Oct 11, 2023
Breast Cancer Trial in Ann Arbor (Breast cancer decision aid)
Recruiting
- Breast Cancer
- Breast cancer decision aid
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Aug 31, 2022
Breast Cancer Female, Breast Cancer, Breast Cancer, Early-Onset Trial (Robotic NSM, Open NSM)
Not yet recruiting
- Breast Cancer Female
- +2 more
- Robotic NSM
- Open NSM
- (no location specified)
Jan 30, 2023
Breast Cancer Trial (GSK3326595)
Completed
- Breast Cancer
-
London, Ontario, CanadaSt. Joseph's Health Care London
Oct 24, 2022
Peripheral Neuropathy, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Columbus (Educational
Completed
- Peripheral Neuropathy
- +6 more
- Educational Intervention
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Oct 10, 2022
Breast Cancer Invasive, Hormone-receptor-positive Breast Cancer, HER2 Low Breast Carcinoma Trial in Guangzhou (Pyrotinib,
Not yet recruiting
- Breast Cancer Invasive
- +3 more
- Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
- Placebo, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Nov 17, 2023
Breast Cancer Trial in Ottawa (On-demand personalized follow-up care, Guideline-based follow-up care (standard of care))
Recruiting
- Breast Cancer
- On-demand personalized follow-up care
- Guideline-based follow-up care (standard of care)
-
Ottawa, Ontario, CanadaThe Ottawa Hospital Cancer Centre
Sep 13, 2022
Breast Tumors Trial in Beijing (Preoperative MRI-guided tumor-bed boost and postopreative ultra-hypofractionated radiotherapy
Recruiting
- Breast Neoplasms
- Preoperative MRI-guided tumor-bed boost and postopreative ultra-hypofractionated radiotherapy (26 Gy/5.2Gy/5)
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Nov 1, 2022
Breast Cancer, Hyperinsulinism, HER2-negative Breast Cancer Trial in New Haven (Dapagliflozin 10mg)
Not yet recruiting
- Breast Cancer
- +2 more
- Dapagliflozin 10mg
-
New Haven, ConnecticutYale Cancer Center Smilow Cancer Hospital
Aug 3, 2023
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +2 more
- Comprehensive Geriatric Assessment
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jun 23, 2023